A2A Pharmaceuticals, Inc. 4
4 · Biomea Fusion, Inc. · Filed May 10, 2023
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-05-08$33.99/sh−100,000$3,399,310→ 3,800,000 total - Sale
Common Stock
2023-05-09$34.50/sh−150,000$5,175,720→ 3,650,000 total
Footnotes (2)
- [F1]A total of 100,000 shares were sold at an average price of 33.9931 in multiple transactions in a range of 33.01 to 34.855. Details of the specific transactions are available upon request.
- [F2]A total of 150,000 shares were sold at an average price of 34.508 in multiple transactions in a range of 33.61 to 35.64. Details of the specific transactions are available upon request.